DeepMatter Group PLC Strong adoption of ICSYNTH (2679C)
October 16 2020 - 1:00AM
UK Regulatory
TIDMDMTR
RNS Number : 2679C
DeepMatter Group PLC
16 October 2020
16 October 2020
DeepMatter Group plc
("DeepMatter", the "Company" or "the Group")
Strong adoption of ICSYNTH
DeepMatter doubles customer numbers for its machine-learning
retrosynthesis tool
DeepMatter (AIM: DMTR), the AIM-quoted company focusing on
digitising chemistry, is pleased to announce it has secured
contracts with five new major customers over the last two months
for its powerful computer aided synthesis design tool, ICSYNTH. In
total, ICSYNTH customer numbers have more than doubled through the
course of 2020, and the Company has achieved 100% customer
renewals, adding to the Group's underlying revenue base. The new
customers include some of the world's leading multi-national
pharmaceutical, agrisciences, biotech and contract research
organisations (CROs). Retrosynthesis is a growing area of the Life
Sciences Research & Development space, providing an increasing
opportunity for ICSYNTH.
ICSYNTH is a powerful computer aided synthesis design tool that
enables chemists to generate synthetic pathways for a target
molecule, leading to better, faster and more cost-effective
synthesis predictions. ICSYNTH facilitates innovation by
stimulating ideas for alternative or novel synthetic routes that
otherwise may not be considered by the chemist.
Development work has recently been completed on a new User
Interface for the tool, facilitating greater ease of use, and new
algorithms have been introduced to filter out erroneous data from
any data source, including proprietary data in Electronic
Laboratory Notebooks, leading to improved synthesis predictions
resulting in better productivity and time management.
Mark Warne, Chief Executive Officer of DeepMatter commented: "We
are delighted to be supplying our powerful retrosynthesis and
forward planning tools to these leaders in their field, expanding
our customer base not only in the Pharmaceutical industry but also
within the agrisciences and CRO sectors.
"With machine learning and cloud technologies both powerful
tools in the race to accelerated drug discovery, we see a growing
opportunity for both our ICSYNTH and DigitalGlassware(TM) platforms
and look to the future with confidence."
For more information, please contact:
DeepMatter Group plc T: 0141 548 8156
Mark Warne, Chief Executive Officer
C anaccord Genuity Limited (Nominated
Advisor and Broker) T: 020 7523 8000
Bobbie Hilliam / Angelos Vlatakis
Alma PR T: 020 3405 0205
Caroline Forde / Harriet Jackson / Kieran deepmatter@almapr.co.uk
Breheny
About DeepMatter Group plc
DeepMatter's long term strategy is to integrate chemistry with
technology, thereby enabling a greater use of artificial
intelligence and reaching a point where chemicals can be
autonomously synthesised through robotics. In the near term this
involves the provision of an integrated software, hardware and
artificial intelligence enabled platform, DigitalGlassware(TM), to
scientists across research and process development sectors.
The DigitalGlassware(TM) platform allows chemistry experiments
to be accurately and systematically recorded, coded and entered
into a shared data cloud. The platform is designed to enable
chemists to work together effectively; sharing the details of their
experiments from anywhere and in real-time, so that work is not
needlessly duplicated, time and money wasted, and ultimately so new
discoveries may be made faster.
Visit: www.deepmatter.io and follow @deepmattergroup
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
CNTMZMMGLKMGGZM
(END) Dow Jones Newswires
October 16, 2020 02:00 ET (06:00 GMT)
Deepmatter (LSE:DMTR)
Historical Stock Chart
From Apr 2024 to May 2024
Deepmatter (LSE:DMTR)
Historical Stock Chart
From May 2023 to May 2024